How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €415.80 | €501.09 |
| Amazon.com Inc. | €224.80 | €258.70 |
| Applied Materials Inc. | €462.25 | €496.17 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €90.76 | €91.19 |
| Western Union Co. | €6.18 | €7.01 |
| Socket Mobile Inc. | ? | - |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Western Digital Corp. | RudolfL | 17.87% |
| B Semtech Corp. | Needham & Company LLC | 12.17% |
| B Ceva Inc. | TD Cowen | 10.53% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Socket Mobile Inc. | Bankster | -55.00% |
| S Capricor Therapeutics Inc | Bankster | -22.55% |
| S Capricor Therapeutics Inc | Vassago1 | -10.07% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Space X
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
China Sxt Pharmaceuticals Inc.
WKN: A411L7 / Name: China Sxt Pharmaceuticals Inc. / Stock / ? /
Pros
Cons
EyePoint Pharmaceuticals Inc.
WKN: A2QJRU / Symbol: EYPT / Name: EyePoint Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Sandisk Corp. | €1,540.0 | 7.690% |
| Marvell Technology Inc. | €205.30 | 7.040% |
| Lumentum Holdings Inc | €851.10 | 6.350% |
| Ciena Corp. | €393.00 | 6.040% |
| Carnival Paired Ctf | €23.45 | 5.850% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Constellation Brands Inc. | €112.50 | -6.640% |
| Charter Communications Inc. A | €126.14 | -5.400% |
| Adobe Inc. | €217.20 | -4.840% |
| Molson Coors B | €35.21 | -4.760% |
| ServiceNow Inc. | €102.20 | -4.660% |
Courses
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
sharewise Introduction
Predictions
BioMarin Pharmaceutical Inc.
18:30
17.08.27
17:55
Top News
D-Wave Has Momentum—What Does It Need to Keep It Going?
Key Points
- Interested in D-Wave Quantum Inc.? Here are five stocks we like better.
- D-Wave Quantum's stock has fluctuated as investors weigh its technological progress against inconsistent
TSMC’s Insider Buying Wave Comes With a Bigger AI Question for Investors
Key Points
- Interested in Taiwan Semiconductor Manufacturing Company Ltd.? Here are five stocks we like better.
- Taiwan Semiconductor insiders, including its CEO, CFO, and COO, have accelerated
HIVE Digital Technologies Q1 Earnings Call Highlights
Key Points
- Interested in HIVE Digital Technologies Ltd.? Here are five stocks we like better.
- Revenue surged 73% year over year to $79.1 million, driven primarily by Bitcoin mining, while
argenx VYVGART Hits Phase III Goal in Autoimmune Myositis, Eyes IMNM Filing
Key Points
- Interested in argenex SE? Here are five stocks we like better.
- VYVGART Hytrulo met the Phase III primary endpoint in the combined immune-mediated necrotizing myopathy (IMNM) and
Cosan Q2 Earnings Call Highlights
Key Points
- Interested in Cosan S.A. Sponsored ADR? Here are five stocks we like better.
- Debt reduction accelerated: Cosan’s expanded net debt fell 20% sequentially to BRL 9.2 billion, supported
Is Airbus Strengthening Its Position in Military Helicopters?
Airbus SE EADSY is strengthening its position in the global military helicopter market through its Airbus Helicopters business. Rising defense spending, fleet modernization and demand for versatile
Is the Options Market Predicting a Spike in LegalZoom.com Stock?
Investors in LegalZoom.com, Inc. LZ need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 18, 2026 $2 Put had some of the highest implied
Empire State Number Highest in 4 Years
This week, we transfer focus to “Retail Earnings Week,” where the biggest of the big-box retailers report quarterly earnings. It also signifies earnings season overall nearing its end until we pick
Can GE Vernova's $176B Backlog Sustain Its Growth Momentum?
GE Vernova Inc. GEV has entered into latter half of 2026 with a robust backlog that strengthens its revenue outlook. As electricity consumption continues to rise, growing demand for the company’s
Community Health Trades at a Deep Discount to Peers: Hold or Fold?
Community Health Systems, Inc. CYH is seeing improving operating volumes, along with continued progress in cost control, clinical quality, and patient experience. Recent divestitures are
Should You Buy, Hold or Sell QUBT Stock Amid Semiconductor Boom?
The Semiconductor Industry Association’s August 2026 report showed that global semiconductor sales reached $403.3 billion in the second quarter of 2026, up 35.1% from the first-quarter level. Robust
News
RLI's Underwriting Discipline Supports Consistent Profitability
RLI Corp.’s RLI decentralized underwriting model supports strong underwriting profitability by giving individual business units significant autonomy to assess risks, price policies and select
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
Align Technology ALGN is dealing with a new U.K. tax issue in 2026. A July Upper Tribunal decision overturned the prior value-added tax exemption for clear aligners, adding a fresh earnings and
Can Tenet Healthcare's Hospital Growth Keep Earnings Momentum Going?
Tenet Healthcare Corporation’s THC second-quarter 2026 results show why its Hospital Operations segment remains an important earnings driver. Despite pressure from weaker exchange enrollment, the
ETFs to Buy as JPMorgan Races to Become the First $1 Trillion Bank
JPMorgan Chase & Co. JPM with a market capitalization of approximately $965 billion, stands on the brink of a defining moment in financial history. As Wall Street's dominant lender, its shares have
ETFs to Buy as Cisco Shares Sink Despite Surpassing Q4 Earnings
Shares of Cisco Systems CSCO fell as much as 8.4% in the immediate trading session following the release of its fourth-quarter and full-year fiscal 2026 financial results. Despite reporting record
NBIX Stock Dips 12% in a Month: Time to Buy, Hold or Sell?
Shares of Neurocrine Biosciences NBIX have lost about 12% over the past month, despite encouraging second-quarter 2026 earnings and an upgraded outlook reported toward the end of last month.
The
Is CVS Stock a Buy as Earnings Improve but Key Risks Remain Elevated?
CVS Health CVS is entering the second half of 2026 with stronger earnings momentum, higher cash generation and an improved Aetna profit outlook. Those gains strengthen the recovery case after a
Reasons Why You Should Retain RSG Stock in Your Portfolio Now
Republic Services, Inc. RSG is gaining from continued demand for its essential waste services across North America. The company’s disciplined pricing strategies and robust Collection segment growth
Northern Oil and Gas Q2 Earnings Beat Estimates, Decline Y/Y
Northern Oil and Gas, Inc. NOG reported second-quarter 2026 adjusted earnings per share of $1.13, which beat the Zacks Consensus Estimate of $1.02. The outperformance reflects strong natural gas
Contest
Still running
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.